1887
Preview this article:
Zoom in
Zoomout

Comparative activity of ertapenem and piperacillin–tazobactam in a murine systemic infection model with and , Page 1 of 1

| /docserver/preview/fulltext/jmm/56/11/1576-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47486-0
2007-11-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/11/1576.html?itemId=/content/journal/jmm/10.1099/jmm.0.47486-0&mimeType=html&fmt=ahah

References

  1. Chapin-Robertson, K. & Edberg, S. ( 1991; ). Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 3rd edn, p. 295–366. Edited by V. Lorian. Baltimore, MD: Williams & Wilkins.
  2. Dela Pena, A. S., Asperger, W., Kockerling, F., Raz, R., Kafka, R., Warren, B., Shivaprakash, M., Vrijens, F., Giezek, H. & other authors ( 2006; ). Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention. J Gastrointest Surg 10, 567–574.[CrossRef]
    [Google Scholar]
  3. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. & Skipper, H. E. ( 1966; ). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50, 219–244.
    [Google Scholar]
  4. Goldstein, E. J. C. & Snydman, D. R. ( 2004; ). Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. J Antimicrob Chemother 53 (Suppl 2), ii29–ii36.
    [Google Scholar]
  5. Goldstein, E. J., Citron, D. M. & Cherubin, C. E. ( 1991; ). Comparison of the inoculum effect of cefoxitin and other cephalosporins and of β-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group. Antimicrob Agents Chemother 35, 1868–1874.[CrossRef]
    [Google Scholar]
  6. König, C., Simmen, H. P. & Blaser, J. ( 1998; ). Bacterial concentrations in pus and infected peritoneal fluid - implications for bactericidal activity of antibiotics. J Antimicrob Chemother 42, 227–232.[CrossRef]
    [Google Scholar]
  7. Li, C., Kuti, J. L., Nightingale, C. H., Mansfield, D. L., Dana, A. & Nicolau, D. P. ( 2005; ). Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection. J Antimicrob Chemother 56, 388–395.[CrossRef]
    [Google Scholar]
  8. Majumdar, A. K., Musson, D. G., Birk, K. L., Kitchen, C. J., Holland, S., McCrea, J., Mistry, G., Hesney, M., Xi, L. & other authors ( 2002; ). Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob Agents Chemother 46, 3506–3511.[CrossRef]
    [Google Scholar]
  9. NCCLS ( 2003; ). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, approved standard, 6th edn, M7–A6. Wayne, PA: National Committee for Clinical Laboratory Standards.
  10. NCCLS ( 2004; ). Methods for Antimicrobial Susceptibility Testing for Anaerobic Bacteria, approved standard, 6th edn, M11–A6. Wayne, PA: National Committee for Clinical Laboratory Standards.
  11. Nix, D. E., Majumdar, A. K. & DiNubile, M. J. ( 2004; ). Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother 53 (Suppl 2), ii23–ii28.
    [Google Scholar]
  12. Santos, K. V., Diniz, C. G., Coutinho, S. C., Apolônio, A. C. M., Sousa-Gaia, L. G., Nicoli, J. R., Farias, L. M. & Carvalho, M. A. R. ( 2007; ). In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed cultures. J Med Microbiol 56, 798–802.[CrossRef]
    [Google Scholar]
  13. Solomkin, J. S., Yellin, A. E., Rotstein, O. D., Christou, N. V., Dellinger, E. P., Tellado, J. M., Malafaia, O., Fernandez, A., Choe, K. A. & other authors ( 2003; ). Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 237, 235–245.
    [Google Scholar]
  14. Stearne, L. E., van Boxtel, D., Lemmens, N., Goessens, W. H., Mouton, J. W. & Gyssens, I. C. ( 2004; ). Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Antimicrob Agents Chemother 48, 1688–1698.[CrossRef]
    [Google Scholar]
  15. Wexler, H. M. ( 2004; ). In vitro activity of ertapenem: review of recent studies. J Antimicrob Chemother 53 (Suppl. S2), ii11–ii21.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47486-0
Loading
/content/journal/jmm/10.1099/jmm.0.47486-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error